Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schaper

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of the American Mosquito Control Association|December 28, 1999
Evaluation of Costa Rican copepods (Crustacea: Eudecapoda) for larval Aedes aegypti control with special reference to Mesocyclops thermocyclopoidesS Schaper
The Journal of Biological Chemistry|July 21, 1995
Interaction of the initiator protein DnaA of Escherichia coli with its DNA targetS Schaper, W Messer
Proteins|May 1, 1997
Prediction of the structure of the replication initiator protein DnaAS Schaper, W Messer
Biomedica Biochimica Acta|January 1, 1989
Isolation and some properties of a cathepsin E type proteinase from rat spleenB Wiederanders, S Schaper, H Kirschke
Biomedica Biochimica Acta|January 1, 1986
The azocasein-urea-pepstatin assay discriminates between lysosomal proteinasesB Wiederanders, H Kirschke, S Schaper
Progress in Clinical and Biological Research|January 1, 1985
Protein degradation in rat liver cellsP Bohley, C Hieke, H Kirschke, et al.
MMW Fortschritte Der Medizin|August 25, 2005
[Educational program of type 2 diabetes]A Lücke, S Schaper, M Frank, et al.
Planta|November 19, 2013
Proteolysis in Euglena gracilis : II. Soluble and particle-bound acidic proteinase activities of the cysteine and aspartic types during growth and chloroplast developmentR Krauspe, A Scheer, S Schaper, et al.
Acta Crystallographica. Section D, Biological Crystallography|October 3, 1998
Crystallization and preliminary X-ray crystallographic studies of the 13-fold symmetric portal protein of bacteriophage SPP1P Jekow, S Schaper, D Günther, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 6, 2012
Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorderB Uehleke, S Schaper, A Dienel, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of the American Mosquito Control Association|December 28, 1999
Evaluation of Costa Rican copepods (Crustacea: Eudecapoda) for larval Aedes aegypti control with special reference to Mesocyclops thermocyclopoidesS Schaper
The Journal of Biological Chemistry|July 21, 1995
Interaction of the initiator protein DnaA of Escherichia coli with its DNA targetS Schaper, W Messer
Proteins|May 1, 1997
Prediction of the structure of the replication initiator protein DnaAS Schaper, W Messer
Biomedica Biochimica Acta|January 1, 1989
Isolation and some properties of a cathepsin E type proteinase from rat spleenB Wiederanders, S Schaper, H Kirschke
Biomedica Biochimica Acta|January 1, 1986
The azocasein-urea-pepstatin assay discriminates between lysosomal proteinasesB Wiederanders, H Kirschke, S Schaper
Progress in Clinical and Biological Research|January 1, 1985
Protein degradation in rat liver cellsP Bohley, C Hieke, H Kirschke, et al.
MMW Fortschritte Der Medizin|August 25, 2005
[Educational program of type 2 diabetes]A Lücke, S Schaper, M Frank, et al.
Planta|November 19, 2013
Proteolysis in Euglena gracilis : II. Soluble and particle-bound acidic proteinase activities of the cysteine and aspartic types during growth and chloroplast developmentR Krauspe, A Scheer, S Schaper, et al.
Acta Crystallographica. Section D, Biological Crystallography|October 3, 1998
Crystallization and preliminary X-ray crystallographic studies of the 13-fold symmetric portal protein of bacteriophage SPP1P Jekow, S Schaper, D Günther, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 6, 2012
Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorderB Uehleke, S Schaper, A Dienel, et al.
Pageof 2